Evidence map›Paper›PMID 39610779›Full record

ArticleWorld journal of gastroenterology2024

Advancing prognostic precision in gastric cancer with an immunoinflammatory index.

Hong-Mei Zhang, Guo-Hua Wang, Shan-Wen Sun, Lei Yuan

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hong-Mei ZhangCollege of Life Science, Northeast Forestry University, Harbin 150040, Heilongjiang Province, China.
Guo-Hua WangCollege of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, Heilongjiang Province, China.
Shan-Wen SunCollege of Life Science, Northeast Forestry University, Harbin 150040, Heilongjiang Province, China.
Lei YuanDepartment of Hepatobiliary Surgery, Quzhou People's Hospital, Quzhou 324000, Zhejiang Province, China. icbbsuse@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer remains a major global health challenge with high morbidity and mortality rates. Recent advancements in immunology and inflammation research have highlighted the crucial roles that these biological processes play in tumor progression and patient outcomes. This has sparked new interest in developing prognostic biomarkers that integrate these two key biological processes. In this letter, we discuss the recent study by Ba

Indexed as

Biomarkers, TumorStomach NeoplasmsDisease ProgressionHumansInflammationPrognosisBiomarkers, TumorGastric cancerImmunoinflammatory indexImmunologyInflammationPrognostic biomarkers

Identifiers

PMID39610779
PMCPMC11580602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.